scholarly journals A Precision Medicine Framework for Personalized Simulation of Hemodynamics in Cerebrovascular Disease

Author(s):  
Dietmar Frey ◽  
Michelle Livne ◽  
Heiko Leppin ◽  
Ela Marie Akay ◽  
Orhun Aydin ◽  
...  

Abstract Cerebrovascular disease, in particular stroke, is a major public health challenge. An important biomarker is cerebral hemodynamics. To measure and quantify cerebral hemodynamics, however, only invasive, potentially harmful or time-to-treatment prolonging methods are available. We present a simulation-based approach which allows calculation of cerebral hemodynamics based on the patient-individual vessel configuration derived from structural vessel imaging. For this, we implemented a framework allowing segmentation and annotation of brain vessels from structural imaging followed by 0-dimensional lumped simulation modelling of cerebral hemodynamics. For annotation, a 3D-graphical user interface was implemented. For 0D-simulation, we used a modified nodal analysis, which was adapted for easy implementation by code. The simulation enables identification of areas vulnerable to stroke and simulation of changes due to different systemic blood pressures. Moreover, sensitivity analysis was implemented allowing the live simulation of changes to simulate procedures and disease progression. Beyond presentation of the framework, we demonstrated in an exploratory analysis in 67 patients that the simulation has a high specificity and low to moderate sensitivity to detect perfusion changes in classic perfusion imaging. The presented precision medicine approach using novel biomarkers has the potential to make the application of harmful and complex perfusion methods obsolete.

2021 ◽  
Vol 20 (1) ◽  
Author(s):  
Dietmar Frey ◽  
Michelle Livne ◽  
Heiko Leppin ◽  
Ela M. Akay ◽  
Orhun U. Aydin ◽  
...  

Abstract Background Cerebrovascular disease, in particular stroke, is a major public health challenge. An important biomarker is cerebral hemodynamics. To measure and quantify cerebral hemodynamics, however, only invasive, potentially harmful or time-to-treatment prolonging methods are available. Results We present a simulation-based approach which allows calculation of cerebral hemodynamics based on the patient-individual vessel configuration derived from structural vessel imaging. For this, we implemented a framework allowing segmentation and annotation of brain vessels from structural imaging followed by 0-dimensional lumped simulation modeling of cerebral hemodynamics. For annotation, a 3D-graphical user interface was implemented. For 0D-simulation, we used a modified nodal analysis, which was adapted for easy implementation by code. The simulation enables identification of areas vulnerable to stroke and simulation of changes due to different systemic blood pressures. Moreover, sensitivity analysis was implemented allowing the live simulation of changes to simulate procedures and disease progression. Beyond presentation of the framework, we demonstrated in an exploratory analysis in 67 patients that the simulation has a high specificity and low-to-moderate sensitivity to detect perfusion changes in classic perfusion imaging. Conclusions The presented precision medicine approach using novel biomarkers has the potential to make the application of harmful and complex perfusion methods obsolete.


2020 ◽  
Author(s):  
Dietmar Frey ◽  
Michelle Livne ◽  
Heiko Leppin ◽  
Ela M Akay ◽  
Orhun U Aydin ◽  
...  

AbstractIntroductionCerebrovascular disease is a major public health challenge. An important biomarker is cerebral hemodynamics. To measure cerebral hemodynamics, however, only invasive, potentially harmful or time-to-treatment prolonging methods are available. We present a simulation-based alternative which allows calculation of cerebral hemodynamics based on the individual vessel con figuration of a patient derived from structural vessel imaging.MethodsWe implemented a framework allowing annotation of extracted brain vessels from structural imaging followed by 0-dimensional lumped modelling of cerebral hemodynamics. For annotation, a 3D-graphical user interface (GUI) was implemented. For 0D-simulation, we used a modified nodal analysis (MNA), which was adapted for easy implementation by code. The code was written in-house in java. The simulation GUI allows inspection of simulation results, identification of vulnerable areas, simulation of changes due to different systemic blood pressures. Moreover, sensitivity analysis was implemented allowing the live simulation of changes of variables such as vessel lumen to simulate procedures and disease courses. In two exemplary patients, simulation results were compared to dynamic-susceptibility-weighted-contrast-enhanced magnetic- resonance(DSC-MR) perfusion imaging.ResultsThe successful implementation of the framework allowing individualized annotation and simulation of patients is presented. In two exemplary patients, both the simulation as well as DSC- MRI showed the same results pertaining to the identification of areas vulnerable to ischemia. Sensitivity analysis allows the individualized simulation of changes in vessel lumen and the effect on hemodynamics.DiscussionWe present the first precision medicine pipeline for cerebrovascular disease which allows annotation of the arterial vasculature derived from structural vessel imaging followed by personalized simulation of brain hemodynamics. This paves the way for further development of precision medicine in stroke using novel biomarkers and might make the application of harmful and complex perfusion methods obsolete for certain use cases in the future.


2021 ◽  
pp. 65-66
Author(s):  
Atindra Narayan ◽  
Kuber Sharma ◽  
D.K. Sharma

Background: Hypertension is a major public health challenge and is the third leading killer in the World. The serum uric acid has shown some prognostic importance in essential hypertension Methodology: Acase control study was undertaken in a tertiary care hospital in Gurugram. Seventy ve cases of hypertension and equal number of controls were studied for the hypertension and serum uric acid levels. Results:This study had shown that, majority of the cases and controls were aged 31 – 40 years and females. The blood pressures were signicantly more in the cases than controls. Serum uric acid levels were also signicantly higher in cases than controls. There was no statistically signicant difference in serum uric acid levels between different stages of hypertension. Conclusion:The serum uric acid levels were signicantly higher in cases of hypertension than controls.


1973 ◽  
Vol 62 (1) ◽  
pp. 28-39
Author(s):  
Toshihiro OKADA ◽  
Yasuyuki TAKAGI ◽  
Yoshio SAITO ◽  
Saburo YAMAOKA

Leukemia ◽  
2020 ◽  
Author(s):  
Stefania Trino ◽  
Daniela Lamorte ◽  
Antonella Caivano ◽  
Luciana De Luca ◽  
Alessandro Sgambato ◽  
...  

AbstractIn the era of precision medicine, liquid biopsy is becoming increasingly important in oncology. It consists in the isolation and analysis of tumor-derived biomarkers, including extracellular vesicles (EVs), in body fluids. EVs are lipid bilayer-enclosed particles, heterogeneous in size and molecular composition, released from both normal and neoplastic cells. In tumor context, EVs are valuable carriers of cancer information; in fact, their amount, phenotype and molecular cargo, including proteins, lipids, metabolites and nucleic acids, mirror nature and origin of parental cells rendering EVs appealing candidates as novel biomarkers. Translation of these new potential diagnostic tools into clinical practice could deeply revolutionize the cancer field mainly for solid tumors but for hematological neoplasms, too.


2020 ◽  
Author(s):  
Beatrice Aramini ◽  
Valentina Masciale ◽  
Federico Banchelli ◽  
Roberto D’Amico ◽  
Massimo Dominici ◽  
...  

Lung cancer is one of the leading causes of cancer death among both men and women, making up almost 25% of all cancer deaths. Precision medicine shows promise for improving many aspects of health and healthcare, including tests, drugs, and other technologies that support innovation, with the possibility of new partnerships with scientists in a wide range of specialties. Non–small-cell lung cancer (NSCLC) has become a prominent example of the success of precision medicine in treating solid tumor malignancies. The first step in this process involves new blood-based diagnostics, which can now noninvasively provide clinically useful information. However, the identification of novel biomarkers that could be used in early diagnosis is urgently needed, especially for guiding initial therapy and predicting relapse or drug resistance following the administration of novel targeted therapies.


Nosotchu ◽  
1980 ◽  
Vol 2 (1) ◽  
pp. 8-13
Author(s):  
Hisao Tachibana ◽  
Shin-ichiro Ebihara ◽  
Katsuhiko Nakahara ◽  
Tsuguo Niimi ◽  
Hiroyuki Okayasu

Sign in / Sign up

Export Citation Format

Share Document